CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+6.67%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.14B
AUM Growth
+$2.14B
(+5%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
54.69%
Holding
37
New
3
Increased
14
Reduced
4
Closed
5
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$59.7M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$45.2M |
| 3 |
Viatris
VTRS
|
$45.2M |
| 4 |
Perrigo
PRGO
|
$38.3M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$35.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$79.1M |
| 2 |
SHPG
Shire pic
SHPG
|
$76M |
| 3 |
Tenet Healthcare
THC
|
$67.1M |
| 4 |
GSK
GSK
|
$58.6M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$52.8M |
Sector Composition
| 1 | Healthcare | 83.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| $32.5M | 1.25% | 1,250,000 +435,000 | +53% | +$11.3M |
|
|
ENDP
27
DELISTED
Endo International plc
ENDP
| $23.6M | 0.91% | 2,500,000 | – | – |
|
|
EGRX
28
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $19.8M | 0.76% | +261,100 | New | +$19.8M |
|
29
Zymeworks
ZYME
$1.12B
| $18.5M | 0.71% | +1,250,000 | New | +$18.5M |
|
30
Surgery Partners
SGRY
$2.91B
| $2.01M | 0.08% | 135,084 | – | – |
|
|
CELG
31
DELISTED
Celgene Corp
CELG
| – | – | 0 | – | – |
|
32
Bausch Health
BHC
$2.74B
| – | – | -1,500,000 | Closed | -$23.9M |
|
|
33
Bristol-Myers Squibb
BMY
$96B
| – | – | -1,250,000 | Closed | -$79.1M |
|
|
34
GSK
GSK
$79.9B
| – | – | -1,500,000 | Closed | -$58.6M |
|
35
Prothena Corp
PRTA
$441M
| – | – | -250,000 | Closed | -$9.18M |
|
36
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
DRNA
37
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – | -1,000,000 | Closed | -$9.56M |
|